Cargando…
New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
OBJECTIVE: The antidiabetic properties of metformin are mediated through its ability to activate the AMP-activated protein kinase (AMPK). Activation of AMPK can suppress tumor formation and inhibit cell growth in addition to lowering blood glucose levels. We tested the hypothesis that metformin redu...
Autores principales: | Libby, Gillian, Donnelly, Louise A., Donnan, Peter T., Alessi, Dario R., Morris, Andrew D., Evans, Josie M.M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732153/ https://www.ncbi.nlm.nih.gov/pubmed/19564453 http://dx.doi.org/10.2337/dc08-2175 |
Ejemplares similares
-
Association between kidney function and mortality among incident metformin users: a retrospective cohort study
por: Schorr, M, et al.
Publicado: (2012) -
Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study
por: Connelly, Paul J., et al.
Publicado: (2017) -
Lactic acidosis and severe septic shock in metformin users: a cohort study
por: Doenyas-Barak, Keren, et al.
Publicado: (2016) -
Treatment pathways in people with type 2 diabetes mellitus: a nationwide cohort study of new users of metformin monotherapy in New Zealand
por: Guo, Joyce, et al.
Publicado: (2021) -
Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009)